Cytek Biosciences, Inc.CTKBNASDAQ
LOADING
|||
Operating Income Contraction
Trending higher, below historical average, modest growth trend.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-20.52M
↓ 176% below average
Average (5y)
$-7.44M
Historical baseline
Range
High:$13.66M
Low:$-27.84M
CAGR
+3.5%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-20.52M | +26.3% |
| 2023 | $-27.84M | -1443.5% |
| 2022 | $-1.80M | -119.7% |
| 2021 | $9.16M | -33.0% |
| 2020 | $13.66M | +179.2% |
| 2019 | $-17.26M | - |